(BUSINESS WIRE)-- The Octapharma Group publishes its 2015 annual results reporting revenue of 1.513 billion Euro, representing an increase of 233 million Euro or 18.2% compared with the 2014 figure.
Gross profit in 2015 was 582 million Euro, 140 million Euro higher than in 2014. The reported gross margin improves to 38.5%.
Operating expenses were 231 million Euro, 60 million Euro higher than in 2014, and include the significant investment Octapharma has made to gain access to new technologies for the development of its recombinant product portfolio.
Operating income is reported at 351 million Euro, the highest in the history of Octapharma. Net cash from operating activities is reported at 382 million Euro or 25% of revenue and provides the platform for future investments.
Chairman and Chief Executive of the Octapharma Group, Wolfgang Marguerre, said: “The year 2015 has been another record-breaking year for Octapharma in which we reached sales in excess of 1. ...
Source : http://me-newswire.net//news/17284/en...
				 
		 Mardi 28 Octobre 2025 - 19:45 Tchad : Atelier de Formation sur l'Utilisation des Images par le Volet des Standards des Ménages (EHCVM) | 
		 
		 Lundi 27 Octobre 2025 - 08:47 Tchad : Le Paysage Aouk-Keïta, un patrimoine naturel à préserver | 
		 
		 Lundi 13 Octobre 2025 - 13:25 The Evolution of Premium Financial Data Marketplaces | 
			 
 Menu
 
				  Octapharma Group Publishes 2015 Annual Results Reporting Revenue of €1. ...
			 
					 
					 
					 
					 






